Article citationsMore>>

H. Asahina, K. Yamazaki, I. Kinoshita, et al., “A Phase II Trial of Gefitinib as First-Line Therapy for Advanced Nonsmall Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations,” British Journal of Cancer, Vol. 95, No. 8, 2006, pp. 998-1004. doi:10.1038/sj.bjc.6603393

has been cited by the following article: